News and Trends 5 Jun 2018 French Biotech Raises €40M to Fight Hepatitis B and NASH Enyo Pharma has completed a Series B financing round to start Phase II trials by the end of this year testing its lead compound in two different forms of liver disease. Enyo Pharma, based in Lyon, has raised €40M from OrbiMed and other investors to start two Phase II trials testing its lead drug candidate […] June 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Expert Advice 5 Jun 2018 7 Life Science Marketing Trends That Blew Up in 2018 & How to Use Them Life science and pharmaceutical companies are notoriously cautious toward digital trends. Perhaps you have experienced this in your own company. You may have tried to push a marketing strategy that is almost old-hat in other industries by now, like email autoresponders, only to hear something along the lines of, “We’ve always done it how we’re […] June 5, 2018 - 15 minutesmins - By James Mathison Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2018 British Company Gets a $100M Boost to Develop a Surgical Robotic Arm CMR Surgical has raised an impressive Series B round to develop a robotic arm to help during surgery that mirrors the movement of a human arm. CMR Surgical, based in Cambridge, UK, has raised $100M (€85M) in Series B funding to bring its surgical robot technology closer to a market launch in Europe and the US. […] June 4, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 4 Jun 2018 Meet the German Biotech Behind Adidas’ Biodegradable Shoes The synbio company AMSilk is drawing inspiration from nature to produce sustainable materials for applications ranging from clothing to medicine. I spoke to CEO Jens Klein to find out more about the innovative biodegradable material that has caught Adidas’ eye. In 2016, Adidas showed the world the first prototype of a new running shoe that, […] June 4, 2018 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2018 FDA Puts Clinical Trial for CRISPR Therapy on Hold The FDA has put a hold on CRISPR Therapeutics’ planned Phase I/II trial testing a CRISPR gene-editing therapy in patients with sickle cell disease, which will likely delay the use of CRISPR-based therapies in humans. CRISPR Therapeutics, headquartered in Basel, Switzerland, and its partner Vertex Pharmaceuticals will have to postpone their plans to start a Phase I/II trial […] June 1, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Startup Scout 1 Jun 2018 This Dutch Biotech Gets Inspiration From Snake Venom to Restore Blood Clotting This week we’re in Leiden, the Netherlands, visiting VarmX. The biotech develops therapeutic proteins based on a peptide found in snake venom to restore blood clotting in patients with acute bleeding. Mission: Founded in 2016 as a spin-out from the University of Leiden, VarmX aims to restore blood clotting in patients with acute, internal bleeding after taking […] June 1, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
More News! 31 May 2018 A Trojan Horse of Nanoparticles Could Fight Fungal Infections in Grapevines German researchers have developed nanoparticles that can protect grapevines from a fungal disease that causes great financial damage to winegrowers each year. A research team at the University of Mainz, led by Frederik Wurm, has developed a nanotechnology that can protect and heal grapevines from infestation by the fungal disease Esca. The technology is made of […] May 31, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 31 May 2018 UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies Innovate UK has awarded a grant to Iontas to develop antibodies that block pain transmission by nerve cells in patients with chronic pain. Iontas, based in Cambridge, has been awarded a grant of £556K (€633K) from Innovate UK to develop its antibody platform, KnotBody, for therapeutic applications in chronic pain management. Iontas’ antibody approach could provide […] May 31, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 30 May 2018 How to Close a €3.9B Acquisition Deal for Your Biotech Company Ablynx, one of the big giants in the European biotech arena, closed the final stages of its €3.9B acquisition deal with Sanofi earlier this month, after details were announced in January. Edwin Moses, CEO of Ablynx, shared the company’s success story with attendees at our recent Refresh Meetup in Brussels. The technology behind Ablynx’s success […] May 30, 2018 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 30 May 2018 Biotech in Germany Celebrates the Closing of a €300M Fund High-Tech Gründerfonds (HTGF), a VC with a long track of biotech investments in Germany, has closed a new fund could benefit the country’s biotech scene. High-Tech Gründerfonds is a German VC that provides seed funding to high-tech startups, including several in the biotech space. The firm has now announced the final closing of a third […] May 30, 2018 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2018 This Immunotherapy Could Be The First to Treat Milk Allergy in Children DBV Technologies has shown in a Phase II trial that its skin patch could desensitize over 60% of children with strong milk allergy. DBV Technologies, one of the largest public biotechs in France, is developing a skin patch technology to treat several forms of food allergies. The company has released new, promising data on its milk […] May 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2018 Positive House Dust Mite Immunotherapy Results for UK Biotech British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial last week. It seems to be doing well, with a number of products targeting common allergies in late stage […] May 29, 2018 - 1 minutemin - By Helen Albert Share WhatsApp Twitter Linkedin Email